Drug Approval | July 31, 2022
Casper Pharma completed USFDA pre-approval inspection
The audit is part of the agency's inspection for three product applications filed and slated to be manufactured at this site.
The audit is part of the agency's inspection for three product applications filed and slated to be manufactured at this site.
The hybrid congress will take place from 1-4 June in Copenhagen, as well as virtually
The two companies will work together for the Prospective Evaluation of OrionAI – a revolutionary AI-based Diagnostic Assistant for Histological Examination of a variety of solid tumours beginning with Head and Neck Squamous Cell Carcinoma (HNSCC) Cancer
Wearable patch sensors (smart patches) are rising in popularity, as they offer a wide range of options for medical diagnosis
April 25th is commemorated as World Malaria Day
Shoreline has developed a proprietary methodology to create differentiated iNK cells for large-scale, "off-the-shelf" production
Casper Pharma is a Hyderabad based SEZ company engaged in the formulations business. Post-purchase of shares, the target entity would become a wholly-owned subsidiary of SPL
As a partner with IRIA, the company had a significant booth presence on-ground during the conference.
AbbVie to present 30 abstracts demonstrating its leadership in neuroscience, including continued migraine treatment research across the spectrum of the disease, commitment to patients with advanced Parkinson's disease, and new studies in spasticity and cervical dystonia
A staggering 65% of the TB cases in India are in the 15-45 age group
Subscribe To Our Newsletter & Stay Updated
